Molecular basis of primary renal hyperuricemia. Role of the human urate transporter hURAT1;Molekulare grundlagen der primär-renalen hyperurikämie. Zur rolle des humanen urattransporters hURAT1

Zeitschrift fur Rheumatologie

Volumn 66, Issue 7, 2007, Pages 556-561

  Unger, S ^a   Tausche, A K ^a   Kopprasch, S ^a   Bornstein, S R ^a   Aringer, M ^a   Grassler J ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Gout; Hyperuricemia; URAT1; Urate transport; Uric acid

Indexed keywords

CARRIER PROTEIN; ORGANIC ANION TRANSPORTER; UNCLASSIFIED DRUG; URIC ACID; URIC ACID TRANSPORT PROTEIN;

APICAL MEMBRANE; ARTICLE; CASE CONTROL STUDY; DIAGNOSTIC APPROACH ROUTE; GENE CONTROL; GENE LOSS; GENE MUTATION; GENETIC POLYMORPHISM; GOUT; HUMAN; KIDNEY PROXIMAL TUBULE; UREMIA; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

ARTHRITIS, GOUTY; GENETIC MARKERS; HUMANS; HYPERURICEMIA; KIDNEY TUBULES, PROXIMAL; ORGANIC ANION TRANSPORTERS; ORGANIC CATION TRANSPORT PROTEINS; POLYMORPHISM, GENETIC; URIC ACID; VARIATION (GENETICS);

EID: 36248942062     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-007-0208-y     Document Type: Article

References (25)

1. Zaka R, Williams CJ (2006) New developments in the epidemiology and genetics of gout. Curr Rheumatol Rep 8: 215-223
2. Tausche AK, Unger S, Richter K et al. (2006) Hyperuricemia and gout: diagnosis and therapy. Internist (Berl) 47: 509-522
3. Gröbner W, Zöllner N (2004) Gicht. Z Rheumatol 63: 2-9
4. Mount DB, Kwon CY, Zandi-Nejad K (2006) Renal urate transport. Rheum Dis Clin North Am 32: 313-331
5. Graessler J, Graessler A, Unger S et al. (2006) Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 54: 292-300
6. Emmerson BT, Nagel SL, Duffy DL, Martin NG (1992) Genetic control of the renal clearance of urate: a study of twins. Ann Rheum Dis 51: 375-377
7. Ghei M, Mihailescu M, Levinson D (2002) Pathogenesis of hyperuricemia: recent advances. Curr Rheumatol Rep 4: 270-274
8. Anzai N, Enomoto A, Endou H (2005) Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep 7: 227-234
9. Rafey MA, Lipkowitz MS, Leal-Pinto E, Abramson RG (2003) Uric acid transport. Curr Opin Nephrol Hypertens 12: 511-516
10. Enomoto A, Kimura H, Chairoungdua A et al. (2002) Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417: 447-452
11. Hediger MA, Johnson RJ, Miyazaki H, Endou H (2005) Molecular physiology of urate transport. Physiology (Bethesda) 20: 125-133
12. Anzai N, Jutabha P, Kanai Y, Endou H (2005) Integrated physiology of proximal tubular organic anion transport. Curr Opin Nephrol Hypertens 14: 472-479
13. Roch-Ramel F, Guisan B (1999) Renal transport of urate in humans. News Physiol Sci 14: 80-84
14. Bieber JD, Terkeltaub RA (2004) Gout: on the brink of novel therapeutic options for an ancient disease. Arthritis Rheum 50: 2400-2414
15. Cameron JS, Simmonds HA (2005) Uric acid and the kidney. Oxford University Press, New York
16. Tanaka K, Xu W, Zhou F, You G (2004) Role of glycosylation in the organic anion transporter OAT1. J Biol Chem 279: 14961-14966
17. Price KL, Sautin YY, Long DA et al. (2006) Human vascular smooth muscle cells express a urate transporter. J Am Soc Nephrol 17: 1791-1795
18. Vazquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S et al. (2007) Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 46: 215-219
19. Shima Y, Teruya K, Ohta H (2006) Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese. Life Sci 79: 2234-2237
20. Choi HK, Mount DB, Reginato AM (2005) Pathogenesis of gout. Ann Intern Med 143: 499-516
21. Enomoto A, Endou H (2005) Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol 9: 195-205
22. Hediger MA (2002) Kidney function: gateway to a long life? Nature 417: 393-395
23. Lee SJ, Terkeltaub RA (2006) New developments in clinically relevant mechanisms and treatment of hyperuricemia. Curr Rheumatol Rep 8: 224-230
24. Iwanaga T, Kobayashi D, Hirayama M et al. (2005) Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab Dispos 33: 1791-1795
25. Ichida K, Hosoyamada M, Hisatome I et al. (2004) Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 15: 164-173